Jun 28, 2024 Thou shalt not settle? Servier – the European Court of Justice’s Latest Chapter In the “Pay for Delay” Saga By Bola Ajayi Tone Oeyen Dr. Christopher Stothers Rod Carlton Enrica Schaefer Philipp Baschenhof +3 more... Show less The European Court of Justice (CJEU) handed down its judgment in Servier on 27 June 2024, agreeing with Advocate General Juliane Kokott’s...
Jun 04, 2024 A new regime for a new era: How the EU Product Liability Directive will reshape product liability in Germany By Moritz Becker Patrick Schroeder Martin Mekat Kristina Weiler Anita Bell Hannah Meyer +3 more... Show less Introduction Following years of intense debate among EU institutions, the final compromise text of the new EU Product Liability...
Apr 18, 2024 UK Government responds to Whitehead Review’s findings of systemic bias in UK medical devices By Harriet Hanks Sanjana Canumalla Matt Allison In March, the independent review into equity in medical devices chaired by Professor Dame Margaret Whitehead published its long-awaited...
Mar 01, 2024 Text of the new EU Product Liability Directive is agreed – what happens next? By Harriet Hanks Andrew Austin In brief: The text of the revised new EU Product Liability Directive (PLD) has now been agreed. After intense negotiations resulting in...
Feb 20, 2024 International Arbitration: top trends in 2024 By Ashley Jones Freshfields has launched International arbitration: top trends in 2024. Our annual report, compiled by international arbitration...
Feb 14, 2024 Life sciences – what to expect in 2024 By Harriet Hanks Emma Franck-Gwinnell Adam Golden 2023 was marked by some real success stories in the life sciences and healthcare space, including ground-breaking new weight loss...
Feb 14, 2024 UK MHRA issues Roadmap towards new medical devices rules By Andrew Austin Harriet Hanks Sofia Schaffgotsch Honor May +1 more... Show less Back in September 2021, the UK MHRA launched a Consultation to overhaul the UK’s medical device regulatory regime - see our previous...
Feb 12, 2024 How To Address ESG Risks Arising From Antimicrobial Resistance By Harriet Hanks Kristen Riemenschneider James Smith Jake Reynolds +1 more... Show less Note: This article originally ran in Life Science Leader Antimicrobial resistance (AMR) is a growing global threat: the WHO recognises it...
Dec 06, 2023 Freshfields whistleblowing survey 2023: Spotlight on trends in the healthcare sector By Holly Insley Amelia Lamp In October, we published the results of the Freshfields whistleblowing survey 2023, which gathered the views of over 2,500 individuals...
Nov 20, 2023 UK CMA issues welcome guidance on combination therapy collaborations for life sciences companies By Jenny Leahy Kirsty Brown The UK Competition and Markets Authority (CMA) – following extensive consultation with the Association of the British Pharmaceutical...
Sep 21, 2023 Will the UK follow the EU’s lead in reforming product liability rules? By Harriet Hanks Andrew Austin Emma Franck-Gwinnell In summary: We recently wrote about the UK Government’s wide-ranging consultation on reforming the UK consumer product safety framework...
Aug 24, 2023 Demystifying China’s regulation of ‘human genetic resources’ By Richard Bird Ma Ya Introduction The Chinese government has regulated activities involving the use of human genetic resources (HGRs) since 1998. New...